A cancer diagnosis will directly impact 1 in 2 men and 1 in 3 women in the United States in their lifetime. What's more, the number of new cases is projected to double by 2050. To better inform people about something that hits so close to home for many, I recently discussed the value of cancer care in a three-part blog series.
Part 1 covered patient viewpoints in value assessments, acknowledged the innovation that's improved lives and accounted for the evolution of a medicine's value over time. Part 2 examined patient-reported outcomes and how they impact the analysis of new treatments for cancer and other diseases. Now, in the third and final blog in the series, I'll discuss how value plays an important role when patients consider treatment options.